KLF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.657200E-01
Normal-vs-Stage2
6.362400E-01
Normal-vs-Stage3
1.853600E-01
Normal-vs-Stage4
5.642800E-01
Stage1-vs-Stage2
2.389800E-02
Stage1-vs-Stage3
4.964000E-01
Stage1-vs-Stage4
1.765030E-01
Stage2-vs-Stage3
1.844840E-01
Stage2-vs-Stage4
7.202400E-02
Stage3-vs-Stage4
1.013820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.421600E-01
Normal-vs-AfricanAmerican
5.799600E-01
Normal-vs-Asian
3.925600E-01
Caucasian-vs-AfricanAmerican
9.839000E-01
Caucasian-vs-Asian
4.504200E-01
AfricanAmerican-vs-Asian
6.130000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.623200E-01
Normal-vs-Female
5.412200E-01
Male-vs-Female
9.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.578400E-01
Normal-vs-Age(41-60Yrs)
9.537000E-01
Normal-vs-Age(61-80Yrs)
4.099400E-01
Normal-vs-Age(81-100Yrs)
2.156600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.103000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.014400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.619400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.086150E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.090000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.217800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.371800E-01
Normal-vs-Daily Drinker
2.134200E-01
Normal-vs-Weekly Drinker
3.389200E-01
Normal-vs-Occasional Drinker
8.609800E-01
Normal-vs-Social Drinker
8.424600E-01
Non Drinker-vs-Daily Drinker
6.600000E-01
Non Drinker-vs-Weekly Drinker
8.744400E-01
Non Drinker-vs-Occasional Drinker
2.074600E-01
Non Drinker-vs-Social Drinker
3.858800E-01
Daily Drinker-vs-Weekly Drinker
5.699800E-01
Daily Drinker-vs-Occasional Drinker
1.468030E-01
Daily Drinker-vs-Social Drinker
2.651200E-01
Weekly Drinker-vs-Occasional Drinker
3.511200E-01
Weekly Drinker-vs-Social Drinker
4.580600E-01
Occasional Drinker-vs-Social Drinker
9.303800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.259000E-01
Normal-vs-Grade 2
7.829900E-02
Normal-vs-Grade 3
1.163770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.699700E-03
Grade 1-vs-Grade 3
7.480200E-03
Grade 1-vs-Grade 4
3.259000E-01
Grade 2-vs-Grade 3
4.089400E-01
Grade 2-vs-Grade 4
7.829900E-02
Grade 3-vs-Grade 4
1.163770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.720800E-01
Normal-vs-NonDiabetic
4.722800E-01
Diabetic-vs-NonDiabetic
7.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.513800E-01
Normal-vs-NoPancreatitis
4.901400E-01
Pancreatitis-vs-NoPancreatitis
9.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.997400E-01
Normal-vs-N1
6.570400E-01
N0-vs-N1
8.315900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.791800E-01
Normal-vs-TP53-NonMutant
9.254200E-02
TP53-Mutant-vs-TP53-NonMutant
1.52796999999261E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
